18F-DCFBC Prostate-Specific Membrane Antigen–Targeted PET/CT Imaging in Localized Prostate Cancer
2017; Lippincott Williams & Wilkins; Volume: 42; Issue: 10 Linguagem: Inglês
10.1097/rlu.0000000000001804
ISSN1536-0229
AutoresBarış Türkbey, Esther Mena, Liza Lindenberg, Stephen Adler, Sandra Bednarova, Rose Berman, Anita Ton, Yolanda McKinney, Philip Eclarinal, C. Rowland Hill, George Afari, Sibaprasad Bhattacharyya, Ronnie C. Mease, Maria J. Merino, Paula Jacobs, Bradford J. Wood, Peter A. Pinto, Martin G. Pomper, Peter L. Choyke,
Tópico(s)Urologic and reproductive health conditions
ResumoTo assess the ability of (N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-F-fluorobenzyl-L-cysteine) (F-DCFBC), a prostate-specific membrane antigen-targeted PET agent, to detect localized prostate cancer lesions in correlation with multiparametric MRI (mpMRI) and histopathology.
Referência(s)